PerCP/Cyanine5.5 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, ? PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, ? PerCP/Cyanine5.5 isotype control (open histogram).
See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
103131 25 µg $80.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103132 100 µg $205.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6 and Western blotting7. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
Product Citations
  1. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  2. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  3. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  4. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  5. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  6. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  7. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  8. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  9. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  10. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  11. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  12. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  13. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  14. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  15. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  16. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  17. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  18. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  19. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  20. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  21. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  22. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  23. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  24. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  25. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  26. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  27. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  28. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  29. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  30. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  31. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  32. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  33. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  34. Li N, et al. 2021. eLife. 10:00. PubMed
  35. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  36. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  37. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  38. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  39. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  40. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  41. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  42. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  43. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  44. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  45. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  46. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  47. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  48. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  49. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  50. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  51. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  52. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  53. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  54. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  55. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  56. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  57. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  58. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  59. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  60. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  61. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  62. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  63. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  64. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  65. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  66. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  67. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  68. Christ A, et al. 2018. Cell. 172:162. PubMed
  69. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  70. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  71. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  72. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  73. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  74. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  75. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  76. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  77. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  78. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  79. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  80. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  81. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  82. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  83. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  84. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  85. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  86. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  87. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  88. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  89. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  90. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  91. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  92. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  93. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  94. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  95. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  96. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  97. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  98. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  99. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  100. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  101. Kalafati L, et al. 2020. Cell. 183:771. PubMed
RRID
AB_893344 (BioLegend Cat. No. 103131)
AB_893340 (BioLegend Cat. No. 103132)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Go To Top Version: 3    Revision Date: 08/24/2018

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account